Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (121-130 of 221) with videos related to

Pageof 23
Sort By:
Leukemia Research|December 16, 2014
Evaluation of methods to detect CALR mutations in myeloproliferative neoplasmsAmy V Jones, Daniel Ward, Matthew Lyon, et al.
Annals of Hematology|April 3, 2023
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysisJohannes Lübke, Nicole Naumann, Georgia Metzgeroth, et al.
Blood|April 21, 2017
Response and progression on midostaurin in advanced systemic mastocytosis: <i>KIT</i> D816V and other molecular markersMohamad Jawhar, Juliana Schwaab, Nicole Naumann, et al.
Leukemia|March 27, 2019
Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Sebastian Kluger, et al.
International Journal of Hematology|July 3, 2008
Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemiaKuan-Po Huang, Andrew J Chase, Nicholas C P Cross, et al.
Haematologica|April 23, 2010
The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significanceFiona M Ross, Laura Chiecchio, GianPaolo Dagrada, et al.
British Journal of Haematology|November 28, 2008
No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriageIssa J Dahabreh, Amy V Jones, Michael Voulgarelis, et al.
Genes, Chromosomes & Cancer|July 18, 2006
Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion geneChristoph Walz, Claire Curtis, Susanne Schnittger, et al.
British Journal of Haematology|June 18, 2014
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemiaClaire N Harrison, Nauman Butt, Peter Campbell, et al.
Blood|June 28, 2011
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3Christoph Walz, Philipp Erben, Michael Ritter, et al.
Pageof 23

Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Leukemia Research|December 16, 2014
Evaluation of methods to detect CALR mutations in myeloproliferative neoplasmsAmy V Jones, Daniel Ward, Matthew Lyon, et al.
Annals of Hematology|April 3, 2023
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysisJohannes Lübke, Nicole Naumann, Georgia Metzgeroth, et al.
Blood|April 21, 2017
Response and progression on midostaurin in advanced systemic mastocytosis: <i>KIT</i> D816V and other molecular markersMohamad Jawhar, Juliana Schwaab, Nicole Naumann, et al.
Leukemia|March 27, 2019
Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Sebastian Kluger, et al.
International Journal of Hematology|July 3, 2008
Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemiaKuan-Po Huang, Andrew J Chase, Nicholas C P Cross, et al.
Haematologica|April 23, 2010
The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significanceFiona M Ross, Laura Chiecchio, GianPaolo Dagrada, et al.
British Journal of Haematology|November 28, 2008
No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriageIssa J Dahabreh, Amy V Jones, Michael Voulgarelis, et al.
Genes, Chromosomes & Cancer|July 18, 2006
Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion geneChristoph Walz, Claire Curtis, Susanne Schnittger, et al.
British Journal of Haematology|June 18, 2014
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemiaClaire N Harrison, Nauman Butt, Peter Campbell, et al.
Blood|June 28, 2011
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3Christoph Walz, Philipp Erben, Michael Ritter, et al.
Pageof 23